Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Cellebrite

Tracked across 7 events · 57 articles · First seen Apr 21, 2026 · Last active Aug 20, 2026

Sentiment
19
Attention
4
Events
7
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 10
Business
Impact: Cellebrite announced the appointment of Shiven Ramji as President of Products and Technology, which is expected to drive innovation and execution of its Digital Investigative and Intelligence platform. This appointment is seen as a positive step for the company's future growth and AI adoption.
Apr 30, 2026 · 6 articles
2 10
Business
Impact: Cellebrite announced its participation in several investor conferences, which could increase its visibility among investors and potentially positively impact its stock price.
May 08, 2026 · 7 articles
4 70
Tech
Impact: Cellebrite launched its new AI-powered digital investigative solution, Genesis, which is expected to significantly enhance its product offerings and market position.
Jun 10, 2026 · 6 articles
2 30
Business
Impact: Cellebrite expands its digital forensics portfolio with drone intelligence, reinforcing its leadership and potentially driving revenue growth.
Jul 08, 2026 · 6 articles
0 0
Business
Impact: Cellebrite announced its Q2 2026 earnings date, a routine event with no financial details disclosed.
Jul 21, 2026 · 6 articles
2 70
Tech
Cellebrite DI Ltd. announced on August 19, 2026 that its AI-powered digital investigation platform, Cellebrite Genesis, is now generally available for enterprise organizations and is expanding to more global markets. The expansion follows a successful…
Impact: Cellebrite is the central entity, announcing the enterprise availability and global expansion of its Genesis platform, which is expected to drive adoption and revenue growth.
Aug 19, 2026 · 6 articles
2 -60
Regulatory
Cellebrite DI Ltd. (NASDAQ: CLBT) reported Q2 2026 financial results that missed revenue expectations, lowered full-year ARR and revenue guidance, and announced a CEO transition. The company reported ARR of $507.8 million, below the $510-$513…
Impact: Cellebrite is the subject of the investigation. Its Q2 earnings miss and guidance cut triggered a sharp stock decline and legal scrutiny, damaging investor confidence and potentially leading to financial liabilities.
Aug 14, 2026 · 20 articles
90 Cellebrite missed revenue expectationsCellebrite Q2 Miss...
80 Cellebrite expanded availabilityCellebrite Genesis...
60 Cellebrite announced CEO transitionCellebrite Q2 Miss...
60 Cellebrite added Deep InvestigatorCellebrite Genesis...
ERGEN INTELLIGENCE
Track Cellebrite live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.